Third Party Pharma Manufacturing in India: A Practical Partner Checklist

Third party pharma manufacturing lets a brand owner launch medicines without owning a factory. The manufacturing partner produces the product under its licence, and the brand owner handles marketing and sales. The model is common in India because the country has a large base of WHO-GMP approved plants that make tablets, capsules, syrups, injections and ointments for other companies. Choosing the right partner is the most important decision in this model. A weak partner causes delayed batches, failed tests and lost customers. Before signing, a brand owner should check the following points. 1. Approvals for the exact plant. Ask which site will make your product and ask for copies of its WHO-GMP certificate and state drug licence. Certificates for a sister plant do not count. 2. Product range and capacity. Make sure the plant already makes the dosage forms you need, and that it has spare capacity in the months you plan to launch. 3. Minimum order quantity. Small brands should confirm the minimum batch size before they commit, because a large first order ties up cash. 4. Quality testing. Ask which tests are done in the plant laboratory and which go to an outside lab, and ask for a sample certificate of analysis. 5. Artwork and packing. Agree who prepares artwork, who approves it and who pays for printed packing material that is left over after a design change. 6. Lead time. Get a written timeline from artwork approval to dispatch, including stability testing for new products. 7. Ownership and exit. Put in writing who owns the brand, artwork and registration documents, and what notice is needed to end the agreement. A partner who answers these questions clearly and in writing is usually a partner who will deliver on time. Vinix BioPharma has published a detailed guide on how to choose a third party manufacturing pharma company in India, covering approvals, contract terms and the questions buyers should ask during a plant visit.